Cancer, prostate

All articles from this key word are listed below.

Benign prostatic hyperplasia Lithotripsy Cancer, prostate Urinary retention Cancer, bladder Transurethral electrovaporizationof the prostate (TUVP)Transurethral resection of the prostate (TURP)

Volume 2, Number 1 Meeting Reviews

Innovative Strategies Proposed at the Western AUA Meeting

75th Annual Meeting, Western Section, American Urological Association

Arie S Belldegrun Allan J Pantuck

Cancer, prostate Transplantation Erectile dysfunction Androgens Benign prostatic hyperplasia (BPH)Carcinoma, renal cell Carcinoma,transitional cell Imaging techniques

Volume 18, Number 4 Prostate Cancer Academy

Prostate Cancer Survivorship: Implementation of Survivorship Care Plans to Meet the Mandate and Enhance Urologic Practice Through Collaborative Care

Alison M Rasper Ryan P Terlecki

Prostate cancer is the most common malignancy among the male survivorship population in the United States, representing 44% of approximately 7 million survivors. In the era of modern medicine and value-based care, successfully treating only the cancer is not sufficient. The cancer survivor represents an individual in need of restoration and protection against future events. A well-designed and well-supported survivorship program not only meets a mandate for accreditation, it logically translates into better patient care. This review summarizes the history of the survivorship movement, outlines some key elements of a survivorship program, and highlights the opportunity to apply these principles to improve cancer-related care, develop relationships with colleagues that may allow increased identification of men at risk, and expand both the experience and outcomes of individual specialists within men’s health. [Rev Urol. 2016;18(4):214-220 doi: 10.3909/riu0733] © 2016 MedReviews®, LLC

Cancer, prostate Survivorship care plan Cancer surveillance

Volume 18, Number 4 Prostate Cancer Academy

Prostate Cancer Academy 2016: Presentation Summaries

Immunotherapy Androgen deprivation therapy Cancer screening Cancer, prostate Robotic simple prostatectomy Intensity-modulated radiation therapy

Volume 18, Number 4 Review Articles

Frequency of Gleason Score 7 to 10 in 5100 Elderly Prostate Cancer Patients

Cancer Screening Update

Navin Shah Vladimir Ioffe

Men 70 to 80 years of age are known to have an increased incidence of high-grade (Gleason sum score [GSS] 7-10) prostate cancer. We determined the frequency of high-grade prostate cancer among men 70 to 80 years old in our practice. We retrospectively reviewed our 5100 prostate cancer patients who are 70 to 80 years old and who opted for radiation therapy (external radiation, brachytherapy, or combination). Data were gathered on race, prostate-specific antigen value, digital rectal examination (DRE) results, and GSS. Patients were further subdivided by age in two categories, those 70 to 75 years and 76 to 80 years, and also by time period: 2006-2010 and 2011-2015. In patients 70 to 75 years, 1426 patients had a GSS of 6 (41%) and 2042 patients had a GSS of 7 to 10 (59%). In patients 76 to 80 years old, 553 had a GSS of 6 (34%) and 1079 had a GSS of 7 to 10 (66%). In 1432 patients with an abnormal DRE result, the GSS was 6 in 376 (26%) and GSS was 7 to 10 in 1059 (74%). Based on analysis of 5100 prostate cancer patients in our practice, we determined that 61% of patients age 70 to 80 have a high-grade prostate cancer, as do 59% of patients age 70 to 75 years, and 66% of patients between age 76 and 80 years. Because biopsy underestimates the grade in GSS 6 patients by 50%, the actual frequency is approximately 80%. In patients with prostate cancer who had an abnormal DRE result, 74% had a GSS of 7 to 10—approximately 85% when accounting for biopsy under-grading. [Rev Urol. 2016;18(4):181-187 doi: 10.3909/riu0732] © 2016 MedReviews®, LLC

Cancer, prostate Gleason score Age

American Urological Association Annual Meeting

NYU Post-Graduate Medical School Course

19th Annual Jackson Hole Urologic Conference

Prostate Cancer

Therapeutic Challenges

Baus Annual Meeting

75th Annual Meeting, Western Section, American Urological Association

Cancer Screening Update

Main Content

Top Content